Family Medicine · Farmington, MO
NPI
1154373017
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
555 W Pine St Ste 300
Farmington, MO, 63640
Phone (573) 747-1510
Groups this clinician bills Medicare through
Medicare paid, 2024
$196K
8,145 services
Medicare patients, 2024
787
Average age 72
Drug cost, 2024
$4.3M
62,286 prescriptions
Company payments, 2025
$2,776
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul S Moniz was code J1010 (injection, methylprednisolone acetate, 1 mg), 5,040 times for 58 patients. In total Paul S Moniz billed 8,145 services in 77 codes, and Medicare paid $196K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 5,040 | 58 | $0.10 | $492 |
| 99214 Office E&M - Established | Office | 1,151 | 489 | $77.96 | $90K |
| 99213 Office E&M - Established | Office | 364 | 241 | $58.51 | $21K |
| 96372 Injection Administration | Office | 190 | 87 | $9.07 | $1,724 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 140 | 29 | $0.33 | $45.72 |
| 99211 Office E&M - Established | Office | 127 | 51 | $15.58 | $1,979 |
| 99203 Office E&M - New | Office | 68 | 68 | $65.90 | $4,482 |
| 81003 Clinical Chemistry | Office | 54 | 45 | $2.13 | $115 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 41 | 15 | $0.77 | $31.58 |
| 81002 Clinical Chemistry | Office | 37 | 34 | $3.41 | $126 |
| 11042 Debridement | Office | 37 | 13 | $85.55 | $3,165 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 33 | 33 | $113.73 | $3,753 |
| 87426 Immunoassay | Office | 23 | 22 | $34.62 | $796 |
| 71046 X-ray - Chest | Office | 23 | 23 | $16.73 | $385 |
| 99212 Office E&M - Established | Office | 20 | 16 | $37.57 | $751 |
By year: 2022 $343K for 4,693 services; 2023 $142K for 2,674 services; 2024 $196K for 8,145 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 54 | 45 | $2.13 | $115 |
| 81002 Clinical Chemistry | 37 | 34 | $3.41 | $126 |
| 87426 Immunoassay | 23 | 22 | $34.62 | $796 |
| 87428 Infectious Agent Detection by DNA/RNA | 12 | 12 | $63.14 | $758 |
Medicare prescription drug claims, 2024
In 2024, the drug Paul S Moniz prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,629 prescriptions and refills. In total Paul S Moniz wrote 62,286 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,629 | 3,837 | 404 | $29K |
| Levothyroxine Sodium Generic | 2,091 | 2,987 | 295 | $18K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,803 | 1,803 | 356 | $42K |
| Gabapentin Generic | 1,626 | 2,108 | 259 | $24K |
| Furosemide Generic | 1,418 | 1,710 | 199 | $7,697 |
| Omeprazole Generic | 1,377 | 2,124 | 230 | $17K |
| Pantoprazole Sodium Generic | 1,336 | 1,734 | 193 | $15K |
| Amlodipine Besylate Generic | 1,281 | 1,937 | 215 | $7,449 |
| Potassium Chloride Generic | 1,220 | 1,476 | 175 | $19K |
| Eliquis Apixaban | 1,149 | 1,240 | 120 | $445K |
| Lisinopril Generic | 1,079 | 1,580 | 178 | $8,309 |
| Alprazolam Generic | 1,015 | 1,057 | 188 | $5,219 |
| Tramadol Hcl Generic | 951 | 953 | 201 | $8,920 |
| Metformin Hcl Generic | 941 | 1,466 | 161 | $6,807 |
| Montelukast Sodium Generic | 901 | 1,466 | 166 | $8,036 |
Brand drugs: 8,319 claims; generic drugs: 53,327 claims; opioid claims: 3,790.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul S Moniz $2,776 ($2,776 in general payments such as food, travel and fees) from 34 companies. The largest payer was Abbvie Inc. with $512.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 34 | $512 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 13 | $266 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 12 | $214 |
| Pfizer Inc. PFE | 12 | $185 |
| Globus Medical, Inc. GMED | 6 | $153 |
| Novo Nordisk Inc NVO | 11 | $141 |
| Lilly USA, LLC LLY | 5 | $114 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 8 | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $112 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $94.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.